Zino, Leena
Kingma, Jurjen S.
Marzolini, Catia
Richel, Olivier
Burger, David M.
Colbers, Angela
Article History
Accepted: 6 March 2022
First Online: 11 April 2022
Declarations
:
: There is no specific funding for this work.
: The authors declare no conflicts of interest for this work. DB and AC have received honoraria and/or study funding from Janssen, MSD, BMS, Abbvie, Gilead and ViiV Healthcare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: LZ made a substantial contribution to the concept, literature search, interpretation and writing of the original manuscript draft. AC made a substantial contribution to the editing, interpretation and drafting of the manuscript. JK and OR contributed to the critical revision of the pharmacological and clinical aspects and recommendations. CM and DB substantially contributed to the interpretation of the literature data, editing, revising the original manuscript and approving the final version for submission.